Life-saving treatments for children with orphan illnesses often move slowly, if at all, through the federal approval process.
Despite modern high-throughput sequencing, the genetic cause of most rare movement disorders remains unclear. A research team in Bochum and Tübingen has now solved one piece of the puzzle: The ...
Mayo Clinic researchers have identified a rare mutation in the MET gene that can directly cause metabolic dysfunction-associated steatotic liver disease. The mutation disrupts the liver’s ability to ...
GeneDx’s Infinity™ will leverage insights from Komodo’s Healthcare Map ® to unlock faster health economics and outcomes research (HEOR), biopharma innovation, and AI-driven discovery GAITHERSBURG, Md.
Together, NORD and OpenEvidence aim to strengthen the connection between clinical knowledge and patient education, helping ...
As the grandfather of a girl with a rare disease, I’ve learned that for families like ours, hope often comes not as a cure, but as a clinical trial: carefully designed but inevitably exclusive. My ...
DeepRare AI system outperforms doctors at diagnosing rare diseases with 64.4% accuracy on first attempt. Find more about the ...
Across America, millions of parents of children with rare diseases are in a race against time, hoping that new treatments will be developed fast enough to save their kids. Thanks to advances in ...
In today’s healthcare landscape, rare disease patients face uncertainty and challenges accessing necessary therapies due to policy changes that affect insurance coverage.
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a strategic partnership with Komodo Health, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results